The Economic Times  Apr 11  Comment 
Sudhir Valia is a relative of Sun Pharma promoter Dilip Sanghvi and a director on the company’s board. The offer by the low-profile businessman is estimated to be around Rs 7,000 crore.  Apr 10  Comment 
Craig filed in out of the hot Kenyan sun, alongside Kipsigi women carrying jugs of clean water. In the corner of the mud hut, a two-day-old boy and his rail-thin mother clung to life. Craig visited the new family while […]
The Hindu Business Line  Apr 8  Comment 
The fund keeps its balance during volatile market spells while reaching for the sun
The Hindu Business Line  Apr 8  Comment 
NASA’s Parker Solar Probe - humanity’s first mission to the Sun - is undergoing final preparations for its launch scheduled for July 31. The spacecr
Financial Times  Mar 30  Comment 
SolarCity deal raises valid questions about the carmaker’s charming chief executive  Mar 29  Comment 
Latinos account for 31% of professional players and a growing percentage of the fanbase but many owners line up with presidential policies seen as hostile In between rounds of batting practice in the Florida sun, the Venezuelan-born Minnesota...
Channel News Asia  Mar 28  Comment 
MADRID: Sun-drenched Spain should be a natural for solar energy, and it is here that the technology is making an effort to stand on its feet financially without subsidies. Investors are now betting again on solar power generation in Spain, which...
The Economic Times  Mar 27  Comment 
The Nifty Pharma index was trading 0.77 per cent up at 8,455 around 11:35 am (IST).
FiercePharma  Mar 23  Comment 
China and U.S.-based 6 Dimensions Capital invest in several high-profile biotechs; Sun Pharma turns to specialty pharma with its newly FDA-approved psoriasis drug Ilumya; China plans to remove the tariff on anticancer drugs; plus more pharma...
FiercePharma  Mar 22  Comment 
Sun Pharma’s 2014 licensing deal with Merck & Co. just paid off. But now, another challenge begins. The newly approved Ilumya will have to go up against established psoriasis player Johnson & Johnson.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki